mitoxantrone has been researched along with Carcinoma, Bronchogenic in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kramer, BS | 1 |
| Gams, R | 1 |
| Birch, R | 1 |
| Einhorn, L | 1 |
| Buchanan, R | 1 |
1 other study available for mitoxantrone and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
Topics: Anthraquinones; Antineoplastic Agents; Carcinoma, Bronchogenic; Drug Evaluation; Humans; Lung Neopla | 1984 |